Sorrento Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2008
Cash & Equivalents	23.63	36.67	56.46	80.77	213.33	20.43	82.4	39.04	71.9	31.67	Upgrade
Short-Term Investments	26.34	90.22	0	0	0	0.44	1.11	97.37	0	0	Upgrade
Cash & Cash Equivalents	49.98	126.88	56.46	80.77	213.33	20.87	83.5	136.4	71.9	31.67	Upgrade
Cash Growth	-60.61%	124.71%	-30.09%	-62.14%	922.18%	-75.01%	-38.78%	89.71%	127.06%	521.98%	Upgrade
Receivables	24.47	18.72	15.51	14.45	3.83	2.21	1.7	0.9	0.73	0.39	Upgrade
Inventory	9.98	8.11	1.83	3.36	2.9	0	0	0	0	0	Upgrade
Other Current Assets	11.95	19.29	12.43	-31	-40.5	6.62	4.45	3.71	1.28	0.57	Upgrade
Total Current Assets	96.37	172.99	86.23	67.59	179.56	29.7	89.65	141.02	73.92	32.63	Upgrade
Property, Plant & Equipment	138.44	126.5	73.91	76.27	24.38	19.35	12.71	7.25	2.28	2.44	Upgrade
Long-Term Investments	17.18	51.27	256.4	262.24	264.99	270.01	189	170.13	10	0	Upgrade
Goodwill and Intangibles	217.17	339.23	117.23	101.61	104.58	109.31	106.31	24.54	28.4	57.36	Upgrade
Other Long-Term Assets	3.69	4.83	2.05	49.93	50.57	3.25	3.91	0.59	26.95	0.15	Upgrade
Total Long-Term Assets	376.47	521.83	449.59	490.04	444.52	401.91	311.93	202.5	67.63	59.95	Upgrade
Total Assets	472.84	694.82	535.82	557.63	624.09	431.61	401.59	343.52	141.54	92.58	Upgrade
Accounts Payable	47.52	27.41	24.71	28.54	25.13	63.12	56.64	13.34	1.66	2.15	Upgrade
Deferred Revenue	7.75	120.05	117.67	118.03	118.98	123.15	144.04	110.9	1.02	0.12	Upgrade
Current Debt	30.17	43.52	26.83	39.58	10.15	0	0.21	4.84	3.32	0.37	Upgrade
Other Current Liabilities	242.49	-51.53	-72.73	-70.95	-92.64	-107.32	-124.81	-98.2	3.56	2.84	Upgrade
Total Current Liabilities	327.92	139.45	96.48	115.21	61.62	78.96	76.09	30.87	9.56	5.48	Upgrade
Long-Term Debt	104.34	194.06	142.56	251.2	223.14	5.21	47.11	4.39	8.83	4.43	Upgrade
Other Long-Term Liabilities	62.25	283.18	156.05	158.47	131.83	140.84	191.89	167.31	14.44	15.86	Upgrade
Total Long-Term Liabilities	166.59	477.24	298.61	409.67	354.97	146.05	239	171.71	23.27	20.29	Upgrade
Total Liabilities	494.51	616.69	395.09	524.88	416.59	225	315.08	202.58	32.83	25.77	Upgrade
Total Debt	134.5	237.58	169.39	290.78	233.29	5.21	47.32	9.23	12.15	4.81	Upgrade
Debt Growth	-43.39%	40.25%	-41.75%	24.65%	4376.80%	-88.99%	412.69%	-24.02%	152.78%	-	Upgrade
Retained Earnings	-1,959.45	-1,386.6	-958.28	-659.82	-367.75	-165.12	-174.25	-113.33	-67.52	-32.86	Upgrade
Comprehensive Income	1.5	1.03	0.52	-0.27	0.02	0.24	-0.12	73.58	0	0	Upgrade
Shareholders' Equity	-18.61	78.75	165.15	78.59	209.47	199.57	80.04	145.15	108.71	66.81	Upgrade
Net Cash / Debt	-84.53	-110.7	-112.93	-210.01	-19.96	15.66	36.19	127.18	59.76	26.86	Upgrade
Net Cash / Debt Growth	-	-	-	-	-	-56.73%	-71.54%	112.82%	122.46%	427.60%	Upgrade
Net Cash Per Share	-0.20	-0.38	-0.49	-1.49	-0.19	0.22	0.72	3.45	2.24	1.79	Upgrade
Working Capital	-231.55	33.54	-10.25	-47.62	117.94	-49.26	13.57	110.15	64.36	27.15	Upgrade
Book Value Per Share	-0.04	0.27	0.72	0.59	1.97	2.86	1.59	3.93	4.08	4.44	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).